{"DataElement":{"publicId":"6680235","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor AJCC Edition 8 Pathologic Distant Metastasis M Category","preferredDefinition":"Extent of the distant metastasis for pancreatic neuroendocrine tumor based on pathologic findings using AJCC Ed. 8 criteria.","longName":"PNET_AJC8_PTH_M_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6679978","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor Pathologic M Category","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. M refers to the presence of metastasis.","longName":"5528371v1.0:2207807v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"5528371","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas","longName":"C27720","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor","conceptCode":"C27720","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F4F7E4E-56D6-7FA1-E053-F662850AC326","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"UMLLOADER_EDRN","dateCreated":"2016-10-20","modifiedBy":"ONEDATA","dateModified":"2016-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207807","version":"1","preferredName":"Pathologic M Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25610:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30F5-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"849C5E1C-53E5-262D-E053-F662850A9871","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"TAYLORT","dateModified":"2019-05-03","changeDescription":"5-3-19 released; tmt. 3/21/19 curated for AJCC ed. 8 content; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6680161","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor American Joint Committee on Cancer Edition 8 Pathologic M Category","preferredDefinition":"A pathologic finding about one or more characteristics of a pancreatic neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system. M refers to the presence of metastasis._A grouping of items based on some commonality or by user defined characteristics.","longName":"6680161v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"cM0","valueDescription":"Pancreatic Neuroendocrine Tumor cM0 TNM Finding v8","ValueMeaning":{"publicId":"6680114","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor cM0 TNM Finding v8","longName":"6680114","preferredDefinition":"Pancreatic neuroendocrine tumor without evidence of distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor cM0 TNM Finding v8","conceptCode":"C135539","definition":"Pancreatic neuroendocrine tumor without evidence of distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849DC067-AD36-667C-E053-F662850AD2D6","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849DCD46-40A4-7A2A-E053-F662850A3677","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"cM1","valueDescription":"Pancreatic Neuroendocrine Tumor cM1 TNM Finding v8","ValueMeaning":{"publicId":"6680112","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor cM1 TNM Finding v8","longName":"6680112","preferredDefinition":"Pancreatic neuroendocrine tumor with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor cM1 TNM Finding v8","conceptCode":"C135540","definition":"Pancreatic neuroendocrine tumor with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849DC067-AD10-667C-E053-F662850AD2D6","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849DCD46-40AE-7A2A-E053-F662850A3677","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"pM1","valueDescription":"Pancreatic Neuroendocrine Tumor pM1 TNM Finding v8","ValueMeaning":{"publicId":"6680104","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor pM1 TNM Finding v8","longName":"6680104","preferredDefinition":"Pancreatic neuroendocrine tumor with distant metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor pM1 TNM Finding v8","conceptCode":"C135546","definition":"Pancreatic neuroendocrine tumor with distant metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849DC067-AC78-667C-E053-F662850AD2D6","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849DCD46-40D6-7A2A-E053-F662850A3677","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"pM1c","valueDescription":"Pancreatic Neuroendocrine Tumor pM1c TNM Finding v8","ValueMeaning":{"publicId":"6680166","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor pM1c TNM Finding v8","longName":"6680166","preferredDefinition":"Pancreatic neuroendocrine tumor with both hepatic and extrahepatic metastases. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor pM1c TNM Finding v8","conceptCode":"C135549","definition":"Pancreatic neuroendocrine tumor with both hepatic and extrahepatic metastases. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849DDB72-08B0-7C0F-E053-F662850AE147","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849DDB72-08C9-7C0F-E053-F662850AE147","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"pM1b","valueDescription":"Pancreatic Neuroendocrine Tumor pM1b TNM Finding v8","ValueMeaning":{"publicId":"6680168","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor pM1b TNM Finding v8","longName":"6680168","preferredDefinition":"Pancreatic neuroendocrine tumor with metastasis in at least one extrahepatic site (e.g., lung, ovary, nonregional lymph node, peritoneum, bone). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor pM1b TNM Finding v8","conceptCode":"C135548","definition":"Pancreatic neuroendocrine tumor with metastasis in at least one extrahepatic site (e.g., lung, ovary, nonregional lymph node, peritoneum, bone). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849DDB72-08D6-7C0F-E053-F662850AE147","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849DDB72-08EF-7C0F-E053-F662850AE147","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"},{"value":"pM1a","valueDescription":"Pancreatic Neuroendocrine Tumor pM1a TNM Finding v8","ValueMeaning":{"publicId":"6680170","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor pM1a TNM Finding v8","longName":"6680170","preferredDefinition":"Pancreatic neuroendocrine tumor with metastasis confined to liver. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor pM1a TNM Finding v8","conceptCode":"C135547","definition":"Pancreatic neuroendocrine tumor with metastasis confined to liver. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849DDB72-08FC-7C0F-E053-F662850AE147","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"849DDB72-0915-7C0F-E053-F662850AE147","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6680160","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor Pathologic Distant Metastasis TNM Finding v8 American Joint Committee on Cancer Pathologic M Category Category","preferredDefinition":"A pathologic finding about one or more characteristics of a pancreatic neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:Caused by or altered by or manifesting disease or pathology.:One criteria of the TNM staging system. M refers to the presence of metastasis.:A grouping of items based on some commonality or by user defined characteristics.","longName":"6680160v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor Pathologic Distant Metastasis TNM Finding v8","conceptCode":"C135545","definition":"A pathologic finding about one or more characteristics of a pancreatic neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system as they pertain to distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"849DCD46-407A-7A2A-E053-F662850A3677","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"ONEDATA","dateModified":"2019-03-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"849DCD46-408B-7A2A-E053-F662850A3677","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"TAYLORT","dateModified":"2019-05-03","changeDescription":"5-3-19 released; tmt. 3/21/19 curated for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506114","version":"1","longName":"Pancreas","context":"MCL","ClassificationSchemeItems":[{"publicId":"5854655","version":"1","longName":"Pancreas Core","context":"MCL"},{"publicId":"7781144","version":"1","longName":"Pancreas PCA Pilot","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000091","version":"1","longName":"Pancreatic","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001793","version":"1","longName":"Pancreas PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"neuroendocrine_pathologic_M_AJCC_8","type":"MCL Alt Name","context":"NCI Standards"}],"ReferenceDocuments":[{"name":"Pathologic M category","type":"Preferred Question Text","description":"Pathologic M category","url":null,"context":"NCI Standards"},{"name":"MCL-PCA-1","type":"Alternate Question Text","description":"Neuroendocrine Pathologic M","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"pancreas_v0-1_template-1.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"849F1A07-4882-3633-E053-F662850A9C49","latestVersionIndicator":"Yes","beginDate":"2019-03-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-21","modifiedBy":"COLBERTM","dateModified":"2021-09-16","changeDescription":"8/17/21 mr Added Alt Name, Ref Doc, to match MCL DD.   5-3-19 released; tmt. 3/21/19 curated for standardization; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}